DU Hong, WEI Guangyou, LIU Jinguang, QIN Rui, HOU Ping. Screening results and factor analysis of retinopathy of prematurity in Bozhou City of Anhui Province[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 48-51. DOI: 10.7619/jcmp.20213103
Citation: DU Hong, WEI Guangyou, LIU Jinguang, QIN Rui, HOU Ping. Screening results and factor analysis of retinopathy of prematurity in Bozhou City of Anhui Province[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 48-51. DOI: 10.7619/jcmp.20213103

Screening results and factor analysis of retinopathy of prematurity in Bozhou City of Anhui Province

More Information
  • Received Date: August 01, 2021
  • Available Online: March 20, 2022
  • Published Date: April 14, 2022
  •   Objective  To investigate screening results and influencing factors of retinopathy of prematurity (ROP) in Bozhou City of Anhui Province.
      Methods  Clinical data of 568 premature infants who hospitalized in department of pediatrics and received fundus examination before discharge were collected, and the related factors for ROP were analyzed.
      Results  In 568 premature infants, ROP developed in 55 infants and the incidence of ROP was 9.7%, including 26 cases in stage 1, 12 cases lesions in stage 2, 7 cases in stage 2 plus disease, 10 cases in stage 3, but no one was in stage 4 and 5. The incidence rates of ROP showed statistically significant differences in premature infants with different gestational age and birth weights (P < 0.01). There were significant differences in oxygen inhalation >3 d, mechanical ventilation and blood transfusion between the non-ROP group and ROP group (P < 0.05). However, no significant differences were found in gender, delivery mode, premature rupture of membranes and number of fetus between the two groups (P > 0.05).
      Conclusion  The incidence rates of ROP are higher in premature infants with smaller gestational age and lower birth weight. The oxygen inhalation time over 3 d, mechanical ventilation and blood transfusion are risk factors for ROP.
  • [1]
    AKKAWI M T, QADDUMI J A S, ISSA H R M, et al. Awareness of retinopathy of prematurity among pediatricians in West Bank, Palestine: a descriptive study[J]. BMC Ophthalmol, 2018, 18(1): 195. doi: 10.1186/s12886-018-0876-1
    [2]
    PRAKALAPAKORN S G, FREEDMAN S F, HUTCHINSON A K, et al. Real-world simulation of an alternative retinopathy of prematurity screening system in Thailand: a pilot study[J]. J Pediatr Ophthalmol Strabismus, 2018, 55(4): 245-253. doi: 10.3928/01913913-20180327-04
    [3]
    GERULL R, BRAUER V, BASSLER D, et al. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis[J]. Arch Dis Child Fetal Neonatal Ed, 2018, 103(4): F337-F342. doi: 10.1136/archdischild-2017-313574
    [4]
    RATRA D, AKHUNDOVA L, DAS M K. Retinopathy of prematurity like retinopathy in full-term infants[J]. Oman J Ophthalmol, 2017, 10(3): 167-172. doi: 10.4103/ojo.OJO_141_2016
    [5]
    TASMAN W, PATZ A, MCNAMARA J A, et al. Retinopathy of prematurity: the life of a lifetime disease[J]. Am J Ophthalmol, 2006, 141(1): 167-174. doi: 10.1016/j.ajo.2005.07.034
    [6]
    罗芳, 章旭平, 温晓芳. 59例早产儿视网膜病变筛查的结果及危险因素[J]. 中国当代医药, 2020, 27(14): 111-113, 117. doi: 10.3969/j.issn.1674-4721.2020.14.031
    [7]
    孟志为. 福州市347例早产儿视网膜病变筛查情况[J]. 吉林医学, 2019, 40(10): 2240-2241. doi: 10.3969/j.issn.1004-0412.2019.10.022
    [8]
    欧阳敏. 赣南地区RetcamⅢ筛查早产儿视网膜病变结果分析[J]. 国外医学: 医学地理分册, 2019, 40(3): 213-215. https://www.cnki.com.cn/Article/CJFDTOTAL-GONE201903003.htm
    [9]
    袁莹莹, 刘海燕. 高危新生儿眼底疾病的筛查与随访研究[J]. 中国医刊, 2019, 54(1): 102-107. doi: 10.3969/j.issn.1008-1070.2019.01.026
    [10]
    中国新生儿重症监护室协作性质量改进研究协作组, 朱艳萍, 蒋思远, 等. 中国多中心新生儿重症监护室胎龄小于34周早产儿出院前视网膜病变发生率的横断面调查[J]. 中国循证儿科杂志, 2020, 15(1): 45-49. doi: 10.3969/j.issn.1673-5501.2020.01.011
    [11]
    李楠, 田宇, 肖玲, 等. 秦皇岛地区早产儿视网膜病变筛查情况分析[J]. 中国斜视与小儿眼科杂志, 2015, 23(2): 26-28. doi: 10.3969/j.issn.1005-328X.2015.02.009
    [12]
    HAUSPURG A K, ALLRED E N, VANDERVEEN D K, et al. Blood gases and retinopathy of prematurity: the ELGAN study[J]. Neonatology, 2011, 99(2): 104-111. doi: 10.1159/000308454
    [13]
    张应金, 陈锦金, 黄润忠, 等. 早产儿视网膜病的高危因素分析[J]. 中国新生儿科杂志, 2014, 29(5): 329-331. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI201123033.htm
    [14]
    吴玉宇, 陈美娟, 江洪清, 等. 早产儿视网膜病变的危险因素分析[J]. 中国妇幼保健, 2014, 29(17): 2743-2745. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201417036.htm
    [15]
    薛幸. 新生儿视网膜病变与妊娠期危险因素和出生后生长发育状况的关系[J]. 眼科新进展, 2012, 32(10): 976-978. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201210024.htm
    [16]
    骆新瑞, 杜娟, 罗晓燕, 等. 四川省早产儿视网膜病变初步筛查结果及危险因素分析[J]. 国际眼科杂志, 2019, 19(5): 813-816. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201905030.htm
    [17]
    RASOULINEJAD S A, MONTAZERI M. Retinopathy of prematurity in neonates and its risk factors: a seven year study in northern Iran[J]. Open Ophthalmol J, 2016, 10: 17-21. doi: 10.2174/1874364101610010017
    [18]
    何俐莹, 易明, 姜小华, 等. 301例早产儿视网膜病变筛查结果及其高危因素分析[J]. 现代生物医学进展, 2019, 19(8): 1503-1507. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201908025.htm
    [19]
    VASAVADA D, SENGUPTA S, PRAJAPATI V K, et al. Incidence and risk factors of retinopathy of prematurity in Western India-Report from A Regional Institute of Ophthalmology[J]. Nepal J Ophthalmol, 2017, 9(18): 112-1120.
    [20]
    王小娟, 赵桂娥, 马小宁, 等. 多学科宣教在早产儿视网膜病变筛查中的效果[J]. 实用临床医药杂志, 2020, 24(15): 123-125. doi: 10.7619/jcmp.202015035
    [21]
    方思文. 早产儿视网膜病变的治疗[J]. 中华实验眼科杂志, 2020, 38(01): 77-80. doi: 10.3760/cma.j.issn.2095-0160.2020.01.016
  • Related Articles

    [1]LIU Ying, DU Likun, HU Lingdan, DU Zhiqiang, CUI Jing. Expression and significance of matrix metalloproteinases and toll-like receptor 9 in patients with acute leukemia[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 120-123, 129. DOI: 10.7619/jcmp.20240984
    [2]ZHANG Lanfang, CHEN Xu, KUAI Jun, QIN Lei, YANG Yan, CHANG Tingmin. Effect of tegafur, gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones, matrix metalloproteinase-2 and matrix metalloproteinase-9 in elderly patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(12): 57-60, 65. DOI: 10.7619/jcmp.20241047
    [3]SUN Ling, LI Tantan, WU Xifeng, MEN Lijie, JIA Meiyan, LU Jun. Correlations of serum tissue inhibitor of metalloproteinases-1, matrix metalloproteinase-9 and vascular endothelial growth factor with degree of myelofibrosis in patients with myeloproliferative neoplasms[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 34-40. DOI: 10.7619/jcmp.20234037
    [4]SHAN Na, ZHAO Li, LIN Xiaodong. Predictive value of serum matrix metalloproteinase-9 and neurofilament light chain levels for cognitive impairment patients after first-onset ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 67-70, 90. DOI: 10.7619/jcmp.20230606
    [5]WANG Fei, SHI Meihong. Relationships of BTB/POZ domain-containing protein 7 and matrix metalloproteinase-9 expression with autoantibodies in labial gland tissues of patients with primary Sjögren's syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 98-102. DOI: 10.7619/jcmp.20220899
    [6]YUAN Shanqi, ZHAO Hongmin, WANG Xiaoye, ZHANG Xi′an, HOU Pengfei, LIU Zhanhui. Application analysis of carotid ultrasound combined with detections of vascular endothelial growth factor, matrix metalloproteinase-9 and hypersensitive C-reactive protein in the stability of atherosclerotic plaque[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 27-29, 33. DOI: 10.7619/jcmp.201917008
    [7]ZHANG Yan, TU Jing, HUANG Hui. Study on the correlation between serum adiponectin and placental matrix metalloproteinase 9 in patients with gestational hypertension[J]. Journal of Clinical Medicine in Practice, 2017, (3): 96-98. DOI: 10.7619/jcmp.201703029
    [8]LU Jianjun, YI Liping, TUO Ya, QIAO Huizhen. Expression and clinical significance of matrix metalloproteinases-9 in tissues of endometrial carcinoma[J]. Journal of Clinical Medicine in Practice, 2014, (15): 63-65,69. DOI: 10.7619/jcmp.201415019
    [9]GAO Mingjun, QI Bo. Influence of irbesartan and amlodipine on carotid-femoral artery pulse wave velocity and serum matrix metalloproteinase-9 level in patients with primary hypertension[J]. Journal of Clinical Medicine in Practice, 2013, (23): 12-14,18. DOI: 10.7619/jcmp.201323004
    [10]ZHANG Yuhua, CAI Xiangzeng, GUO Minghe. Effects of Chuanxiongqin on serum high-sensitivity C-reactive protein, interleukin-6 and matrix metalloproteinases-9 in treating acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2013, (17): 78-80. DOI: 10.7619/jcmp.201317026
  • Cited by

    Periodical cited type(3)

    1. 王娟,郭潍宁,陆小莉,章馨,陶云,沈薛. 妊娠期胎动监测与胎动减少管理最佳证据总结. 全科护理. 2024(17): 3169-3175 .
    2. 姚娟娟,黄秀霞,岳智慧,邓瑾微. 导乐联合哀伤护理在围产期丧失产妇护理中的应用效果. 中国社区医师. 2023(32): 142-144 .
    3. 程彩霞. 单胎妊娠晚期胎死宫内的病因分析与预防策略. 实用妇科内分泌电子杂志. 2023(35): 47-49 .

    Other cited types(0)

Catalog

    Article views (206) PDF downloads (72) Cited by(3)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return